Trial · NCT03204786
Outcomes48
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 48
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Total Scores During Treatment. | baseline, 4-week, 8-week | Participants with available data at the respective time point | T-score | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Clinical Global Impression (CGI) Scores During Treatment. | baseline; 4-week; 8-week | Participants with data at the respective time point | score on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline on Reading the Mind in the Eyes Test (RMET) During Treatment. | baseline; 4-week; 8-week | Participants with data at the respective time point | score on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline on the Facial Emotion Recognition Test During Treatment. | baseline; 4-week; 8-week | Participants with data at the respective time point | score on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Parent Rated Repetitive Behavior Scale Revised (RBS-R) Scores During Treatment. | baseline; 4-week; 8-week | Participants with data at the respective time point | score on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Parent Rated Spence Children's Anxiety Scale (SCAS) During Treatment. | baseline; 4-week; 8-week | Participants with data at the respective time point | score on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline on Electrocardiogram (EKG) P Duration During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | milliseconds | MEAN |
| SECONDARY | Change From Baseline on Electrocardiogram (EKG) PR Interval During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | milliseconds | MEAN |
| SECONDARY | Change From Baseline on Electrocardiogram (EKG) QRS Interval During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | milliseconds | MEAN |
| SECONDARY | Change From Baseline on Electrocardiogram (EKG) QT Interval During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | milliseconds | MEAN |
| SECONDARY | Change From Baseline on Blood Clinical Labs (Sodium) During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | mmol/L | MEAN |
| SECONDARY | Change From Baseline on Blood Clinical Labs (Potassium) During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | mmol/L | MEAN |
| SECONDARY | Change From Baseline on Blood Clinical Labs (Chloride) During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | mmol/L | MEAN |
| SECONDARY | Change From Baseline on Blood Clinical Labs (CO2) During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | mmol/L | MEAN |
| SECONDARY | Change From Baseline on Blood Clinical Labs (Anion Gap) During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | mmol/L | MEAN |
| SECONDARY | Change From Baseline on Blood Clinical Labs (Glucose) During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | mg/dL | MEAN |
| SECONDARY | Change From Baseline on Blood Clinical Labs (Creatinine) During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | mg/dL | MEAN |
| SECONDARY | Change From Baseline on Blood Clinical Labs (Urea Nitrogen) During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | mg/dL | MEAN |
| SECONDARY | Change From Baseline on Blood Clinical Labs (Calcium) During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | mg/dL | MEAN |
| SECONDARY | Change From Baseline on Blood Clinical Labs (Osmolality) During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | mOsm/kg | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03204786/outcomes